Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
06 99 39
Recup number
You may also be interested in:
Social cognition deficit and genetic vulnerability to schizophrenia in 22q11 deletion syndrome.
Authors: Frascarelli M, Padovani G, Buzzanca A, Accinni T, Carlone L, Ghezzi F, Lattanzi GM, Fanella M, Putotto C, Di Bonaventura C, Girardi N, Pasquini M, Biondi M, Di F.
Date: 2020
Scope of interest: Psychiatric disorders/rare diseases
Read details
Role of sedo-analgesia in execution of bone marrow biopsies
Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., .Giannì L, Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M..
Date: 2012
Scope of interest: Haematology
Read details
22q11.2 deletion and epilepsy: syndromic contexts and neurophysiological aspects
Authors: M. Fanella, A. Morano, J. Fattouch, S. Casciato, M. Albini, L.M. Basili, M. Frascarelli, T. Accinni, A. Buzzanca, A.T. Giallonardo, M. Biondi, F. Di Fabio, C. Di Bonaventura
Date: 2018
Scope of interest: Rare diseases/epilepsy
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
